Translational stem cell therapy for amyotrophic lateral sclerosis

Nature Reviews Neurology

Volumn 8, Issue 3, 2012, Pages 172-176

  Boulis, Nicholas M ^a   Federici, Thais ^a   Glass, Jonathan D ^a   Lunn, J Simon ^b   Sakowski, Stacey A ^b   Feldman, Eva L ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C; VASCULOTROPIN;

AMYOTROPHIC LATERAL SCLEROSIS; CELL SELECTION; CLINICAL EFFECTIVENESS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NEURAL STEM CELL; NONHUMAN; PATIENT SAFETY; PRIORITY JOURNAL; REVIEW; SPINAL CORD NERVE CELL; SPINE STABILIZATION; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CLINICAL TRIALS, PHASE I AS TOPIC; DISEASE MODELS, ANIMAL; HUMANS; MAGNETIC RESONANCE IMAGING; NERVE GROWTH FACTORS; STEM CELL TRANSPLANTATION;

EID: 84858161346     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2011.191     Document Type: Review

References (33)

1. Borasio, G. & Miller, R. Clinical characteristics and management of ALS. Semin. Neurosci. 21, 155-166 (2001).
2. Miller, R. H. The promise of stem cells for neural repair. Brain Res. 1091, 258-264 (2006).
3. Rothstein, J. D. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann. Neurol. 65 (Suppl. 1), S3-S9 (2009).
4. Ilieva, H., Polymenidou, M. & Cleveland, D. W. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 187, 761-772 (2009).
5. Bonner, J. F., Blesch, A., Neuhuber, B. & Fischer, I. Promoting directional axon growth from neural progenitors grafted into the injured spinal cord. J. Neurosci. Res. 88, 1182-1192 (2010).
6. Silani, V., Calzarossa, C., Cova, L. & Ticozzi, N. Stem cells in amyotrophic lateral sclerosis: motor neuron protection or replacement? CNS Neurol. Disord. Drug Targets 9, 314-324 (2010).
7. Xu, L., Ryugo, D. K., Pongstaporn, T., Johe, K. & Koliatsos, V. E. Human neural stem cell grafts in the spinal cord of SOD1 transgenic rats: differentiation and structural integration into the segmental motor circuitry. J. Comp. Neurol. 514, 297-309 (2009).
8. Yan, J. et al. Extensive neuronal differentiation of human neural stem cell grafts in adult rat spinal cord. PLoS Med. 4, e39 (2007).
9. Boucherie, C., Schafer, S., Lavand'homme, P., Maloteaux, J. M. & Hermans, E. Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis. J. Neurosci. Res. 87, 2034-2046 (2009).
10. Clement, A. M. et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302, 113-117 (2003).
11. Lepore, A. C. et al. Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat. Neurosci. 11, 1294-301 (2008).
12. Fischer, L. R. & Glass, J. D. Axonal degeneration in motor neuron disease. Neurodegener. Dis. 4, 431-442 (2007).
13. Sakowski, S. A. et al. Neuroprotection using gene therapy to induce vascular endothelial growth factor? A expression. Gene Ther. 16, 1292-1299 (2009).
14. Sakowski, S. A., Schuyler, A. D. & Feldman, E. L. Insulin-like growth factor? I for the treatment of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 10, 63-73 (2009).
15. Sorenson, E. J. et al. Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology 71, 1770-1775 (2008).
16. Suzuki, M. et al. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS ONE 2, e689 (2007).
17. Park, S. et al. Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice. Exp. Mol. Med. 41, 487-500 (2009).
18. Suzuki, M. et al. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Mol. Ther. 16, 2002-2010 (2008).
19. Xu, L. et al. Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats. Transplantation 82, 865-875 (2006).
20. Yan, J. et al. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice. Stem Cells 24, 1976-1985 (2006).
21. Xu, L., Shen, P., Hazel, T., Johe, K. & Koliatsos, V. E. Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats. Neurosci. Lett. 494, 222-226 (2011).
22. Lunn, J. S., Hefferan, M. P., Marsala, M. & Feldman, E. L. Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery. Growth Factors 27, 133-140 (2009).
23. Lunn, J. S. et al. Stem cell technology for the study and treatment of motor neuron diseases. Regen. Med. 6, 201-213 (2011).
24. Tetzlaff, W. et al. A systematic review of cellular transplantation therapies for spinal cord injury. J. Neurotrauma 28, 1611-1682 (2011).
25. Mazzini, L. et al. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a Phase I clinical trial. Exp. Neurol. 223, 229-237 (2010).
26. Chen, L. et al. Short-term outcome of olfactory ensheathing cells transplantation for treatment of amyotrophic lateral sclerosis. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 21, 961-966 (2007).
27. Deda, H. et al. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy 11, 18-25 (2009).
28. Raore, B. et al. Cervical multilevel intraspinal stem cell therapy: assessment of surgical risks in Gottingen minipigs. Spine (Phila Pa 1976) 36, E164-E171 (2011).
29. Riley, J. P., Raore, B., Taub, J. S., Federici, T. & Boulis, N. M. Platform and cannula design improvements for spinal cord therapeutics delivery. Neurosurgery http://dx.doi.org/10.1227/NEU.0b013e3182195680.
30. Usvald, D. et al. Analysis of dosing regimen and reproducibility of intraspinal grafting of human spinal stem cells in immunosuppressed minipigs. Cell Transplant. 19, 1103-1122 (2010).
31. Hefferan, M. P., Johe, K., Feldman, E. L., Lunn, J. S. & Marsala, M. Optimization of immunosuppressive therapy for spinal grafting of human spinal stem cells in a rat model of ALS. Cell Transplant. http://dx.doi.org/10.3727/ 096368910X564553.
32. Guest, J., Benavides, F., Padgett, K., Mendez, E. & Tovar, D. Technical aspects of spinal cord injections for cell transplantation. Clinical and translational considerations. Brain Res. Bull. 84, 267-279 (2011).
33. Bretzner, F., Gilbert, F., Baylis, F. & Brownstone, R. M. Target populations for first-in-human embryonic stem cell research in spinal cord injury. Cell Stem Cell 8, 468-475 (2011).